Grace Therapeutics Inc logo

Grace Therapeutics Inc Share Price Today (NASDAQ: GRCE)

Grace Therapeutics Inc share price is 2.63 & ₹224.59 as on 14 May 2025, 2.30 'hrs' IST

$2.63

-0.09

(-3.31%)

Market is closed - opens 7 PM, 14 May 2025

View live Grace Therapeutics Inc share price in Dollar and Rupees. Guide to invest in Grace Therapeutics Inc stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Grace Therapeutics Inc, along with analyst recommendations, forecasts, and comprehensive financials.

Grace Therapeutics Inc share price movements

  • Today's Low: $2.62
    Today's High: $2.75

    Day's Volatility :4.73%

  • 52 Weeks Low: $1.75
    52 Weeks High: $4.97

    52 Weeks Volatility :64.75%

Grace Therapeutics Inc (GRCE) Returns

PeriodGrace Therapeutics IncIndex (Russel 2000)
3 Months
-20.58%
0.0%
6 Months
-9.51%
0.0%
1 Year
-1.08%
0.0%
3 Years
-50.79%
-1.3%

Grace Therapeutics Inc (GRCE) Key Statistics

in dollars & INR

Previous Close
$2.72
Open
$2.71
Today's High
$2.75
Today's Low
$2.62
Market Capitalization
$35.0M
Today's Volume
$11.3K
52 Week High
$4.965
52 Week Low
$1.75
Revenue TTM
$0.0
EBITDA
$-16.7M
Earnings Per Share (EPS)
$-1.29
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-22.89%

How to invest in Grace Therapeutics Inc Stock (GRCE) from India?

It is very easy for Indian residents to invest directly in Grace Therapeutics Inc from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Grace Therapeutics Inc stock in both Indian Rupees (INR) and US Dollars (USD). Search for Grace Therapeutics Inc or GRCE on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Grace Therapeutics Inc or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Grace Therapeutics Inc shares which would translate to 0.325 fractional shares of Grace Therapeutics Inc as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Grace Therapeutics Inc, in just a few clicks!

Returns in Grace Therapeutics Inc (GRCE) for Indian investors in Rupees

The Grace Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Grace Therapeutics Inc investment value today

Current value as on today

₹96,546

Returns

₹3,454

(-3.45%)

Returns from Grace Therapeutics Inc Stock

₹5,735 (-5.73%)

Dollar Returns

₹2,281 (+2.28%)

Indian investors sentiment towards Grace Therapeutics Inc (GRCE)

-75%

Period: Apr 13, 2025 to May 13, 2025. Change in 30 Days versus previous period

Search interest for Grace Therapeutics Inc Stock from India on INDmoney has decreased by -75% in the last 30 days, reflecting a downward trend in search activity.

Analyst Recommendation on Grace Therapeutics Inc

Rating
Trend

Insights on GRCE Stock (Ticker Symbol: GRCE)

  • Price Movement

    In the last 7 days, GRCE stock has moved down by -8.6%
  • GRCE vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 82.3% return, outperforming this stock by 83.4%
  • GRCE vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 113.2% return, outperforming this stock by 162.1%

Grace Therapeutics Inc (GRCE) Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Regeneron Pharmaceuticals, Inc. logo
0.72%
-28.49%
-41.58%
-12.19%
-0.27%
Vertex Pharmaceuticals Incorporated logo
-11.36%
-11.14%
2.54%
72.91%
52.24%
Alnylam Pharmaceuticals, Inc. logo
12.33%
1.89%
82.3%
115.9%
93.57%

About Grace Therapeutics Inc

Grace Therapeutics, Inc. engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada. The company's lead product candidate is the GTX-104, an intravenous infusion to treat subarachnoid hemorrhage. It also develops GTX-102, an oral mucosal betamethasone spray for the treatment of ataxia-telangiectasia; and GTX-101, a topical bioadhesive film-forming bupivacaine spray for postherpetic neuralgia. The company was formerly known as Acasti Pharma Inc. and changed its name to Grace Therapeutics, Inc. in October 2024. The company was incorporated in 2002 and is headquartered in Princeton, New Jersey.
Organization
Grace Therapeutics Inc
Employees
0
CEO
Mr. Prashant Kohli
Industry
Miscellaneous

Management People of Grace Therapeutics Inc

NameTitle
Mr. Prashant Kohli
CEO & Director
Mr. Amresh Kumar Ph.D.
VP of Program Management
Ms. Carrie D'Andrea
VP of Clinical Operations
Mr. Robert J. DelAversano CPA
VP of Finance and Principal Financial & Accounting Officer
Dr. R. Loch MacDonald M.D., Ph.D.
Member of Scientific Advisory Board & Chief Medical Officer

Important FAQs about investing in GRCE Stock from India :

Can Indians buy Grace Therapeutics Inc shares?

Yes, Indians can invest in the Grace Therapeutics Inc (GRCE) from India.

With INDmoney, you can buy Grace Therapeutics Inc at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Grace Therapeutics Inc at zero transaction cost.

How can I buy Grace Therapeutics Inc shares from India?

It is very easy to buy Grace Therapeutics Inc from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Grace Therapeutics Inc (GRCE) be purchased?

Yes, you can buy fractional shares of Grace Therapeutics Inc with INDmoney app.

What are the documents required to start investing in Grace Therapeutics Inc stocks?

To start investing in Grace Therapeutics Inc, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What is Grace Therapeutics Inc share price today?

Grace Therapeutics Inc share price today stands at $2.63, Open: $2.71 ; Previous Close: $2.72 ; High: $2.75 ; Low: $2.62 ; 52 Week High: $4.97 ; 52 Week Low: $1.75.

The stock opens at $2.71, after a previous close of $2.72. The stock reached a daily high of $2.75 and a low of $2.62, with a 52-week high of $4.97 and a 52-week low of $1.75.

What are today’s High and Low prices of Grace Therapeutics Inc Stock (GRCE)?

Today’s highest price of Grace Therapeutics Inc (GRCE) is $2.75.

Today’s lowest price of Grace Therapeutics Inc (GRCE) is $2.62.

What is the 52 Week High and Low Range of Grace Therapeutics Inc Stock (GRCE)?

  • 52 Week High

    $4.97

  • 52 Week Low

    $1.75

What are the historical returns of Grace Therapeutics Inc (GRCE)?

  • 1 Month Returns

    28.97%

  • 3 Months Returns

    -9.51%

  • 1 Year Returns

    -1.08%

  • 5 Years Returns

    -90.8%

What is today's market capitalisation of Grace Therapeutics Inc?

Today's market capitalisation of Grace Therapeutics Inc GRCE is 35.0M

Who is the Chief Executive Officer (CEO) of Grace Therapeutics Inc ?

Mr. Prashant Kohli is the current Chief Executive Officer (CEO) of Grace Therapeutics Inc.